SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 2, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $175K total
Actionable Insight • Neutral

No material signal from this cluster. The small dollar amounts and concurrent option exercises suggest routine tax-related selling. Monitor for larger insider transactions (>0.5% of market cap) or a cluster of open-market purchases for a directional read.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$25.32
T+0 close · Sep 2, 2026 · via day close
Latest settled
−9.20%
T+20 · $22.99 · next T+60 in 13d
Vs SPY
−8.01%
α at T+20
Latest observation
−32.12%
T+50 · FF3 residual α
  1. T+0 · Sep 3 $25.32entry
  2. T+1 · 2mo ago +3.24%α +3.62% · $26.14
  3. T+5 · 2mo ago −0.87%α +0.28% · $25.10
  4. T+20 · 7w ago −9.20%α −8.01% · $22.99
  5. T+51 · todayOpen
  6. T+60 · in 13d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two C-suite insiders at Nurix Therapeutics (NRIX), Chief Scientific Officer Gwenn Hansen and Chief Legal Officer Christine Ring, sold a combined $175K in open-market transactions over a 2-day window. The total represents ~0.0065% of the company's $2.7B market cap, making the cluster economically trivial and likely driven by routine tax withholding or option-exercise-related sales.

Key Financial Metrics

Direction
selling
Total Value
$175.0K
Insiders
2

Key Facts

  • Chief Scientific Officer Gwenn Hansen sold 1,452 shares at $25.47 for $36,982 on 2026-09-01.
  • Chief Legal Officer Christine Ring sold 5,787 shares at $25.69 for $138,417 on 2026-09-02 (includes 400 shares at $26.64).
  • Both insiders also exercised derivative securities (non-cash) on the same dates, consistent with option-exercise-and-sell patterns.
  • Total insider sales of $175K represent ~0.0065% of NRIX's $2.7B market cap, well below the 0.1% materiality threshold.

Financial Impact

Two C-suite insiders sold $175K total, representing ~0.0065% of market cap, trivial and non-material.

insider activity

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NRIX-1788392609018

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $14.73 −2.90% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $14.73 −4.41% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $15.95 Now $14.73 −7.65% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $14.73 +7.65% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 2, 2026